Leggett & Platt (LEG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Apr, 2026Executive summary
The 2026 annual meeting will be held virtually on May 21, 2026, with advance registration required for participation and voting eligibility set as of March 13, 2026.
Shareholders will vote on the election of eight directors, ratification of PwC as auditor, an advisory say-on-pay vote, and approval of amendments to the Flexible Stock Plan.
Proxy materials and voting instructions are available online, and the Board recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Proposals include: election of eight directors, ratification of PwC as auditor, advisory approval of executive compensation, and amendment/restatement of the Flexible Stock Plan.
All proposals are recommended for approval by the Board.
Shareholders may submit additional business or director nominations per company bylaws.
Board of directors and corporate governance
The Board consists of eight nominees, with a mix of tenure and diversity; five of seven independent nominees are women or racial/ethnic minorities.
Board committees (Audit, HRC, NGS) are composed entirely of independent directors and meet regularly.
Annual self-evaluations and periodic external reviews are conducted for board and committee effectiveness.
Lead Director role ensures independent oversight and communication with shareholders.
Directors are subject to stock ownership guidelines and limits on outside board service.
Latest events from Leggett & Platt
- $2.5B all-stock acquisition expands global reach and targets $50M in annual synergies.LEG
M&A announcement14 Apr 2026 - Shareholders will vote virtually on directors, auditor, compensation, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at 2026 annual meeting.LEG
Proxy filing7 Apr 2026 - Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026 - 2026 outlook: flat-to-down sales, margin gains, and focus on debt reduction amid weak demand.LEG
Q4 202512 Feb 2026 - Q2 loss driven by $675M impairment, lower sales, and restructuring; dividend cut for deleveraging.LEG
Q2 20242 Feb 2026 - Sales and earnings fell, guidance cut, and restructuring, impairment, and deleveraging continue.LEG
Q3 202418 Jan 2026 - Adjusted EPS up to $0.24 despite 7% sales drop; 2025 outlook and deleveraging focus maintained.LEG
Q1 202527 Dec 2025 - Restructuring and cost actions drive margin gains amid weak demand and a cautious 2025 outlook.LEG
Q4 202423 Dec 2025